Intermediate Stroke Risk

DOACs Reduce Cardiovascular Events in Atrial Fibrillation at Intermediate Stroke Risk

In patients with atrial fibrillation at intermediate risk for stroke, direct oral anticoagulant (DOAC) therapy significantly reduced the 24-month risk…

4 weeks ago

This website uses cookies.